None listed
Conditions
Interventions
Drug : Among the patients who underwent gastroscopic biopsy, 10 mg of ilaprazole, a proton pump inhibitor, was orally administered to the test group twice a day for 7 days, and not administered to the
Sponsors
Catholic Kwandong University International St.Mary's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Male or female between the ages of 19 and 70 2) Those who need gastroscopic biopsy 3) These who agreed to participate in this study and voluntarily signed the written consent 4) Those without dementia or cognitive impairment
Exclusion criteria
Exclusion criteria: 1) Those with a history of allergic symptoms (rash, fever, itching, etc.) or hypersensitivity reactions to this research drug 2) Those who have confirmed esophageal stricture, ulcerative stenosis, esophageal varices, and Barrett's esophagus in upper gastrointestinal endoscopy within 1 year of screening 3) H2 receptor antagonist (H2RA), prostaglandin preparation, mucosal protective agent, gastrointestinal motility promoter (Prokinetics), anticoagulant, antiplatelet agent, etc. were taken within 2 weeks of biopsy or proton pump inhibitor (PPI) within 4 weeks of biopsy person who took 4) Pregnant and lactating women 5) A person who is judged inappropriate by the researcher to participate in the study for other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bleeding prevention | — |
Secondary
| Measure | Time frame |
|---|---|
| Abdominal pain survey ;heartburn survey ;quality of life survey | — |
Countries
Korea, Republic of
Contacts
Public ContactIL HYUN BAEK
Catholic Kwandong University International St.Mary's Hospital
Outcome results
None listed